mRNA-based OncoSIGNal pathway activity profiling technology
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
148
NCT03458221
Signal TrAnsduction Pathway Activity Analysis in OVarian cancER
Phase: Phase 2/3
Role: Collaborator
Start: Jan 31, 2023
Completion: Oct 1, 2026
Loading map...